Follow-up study finds a single dose of one drug can ease anxiety and depression for five years

The Journal of Psychopharmacology published a study in 2016 in which researchers found that a one-time, single-dose of psilocybin offered rapid improvements in the levels of anxiety, depression and dread of death in cancer patients. A recent update found that the single dose, combined with psychotherapy, led to long-lasting improvements in these patients approximately five years later.

https://thehill.com